Issue Navigation
-
Review
-
1-11
Global frailty screening tools: Review and application of frailty screening tools from 2001 to 2023
Deng Y, Sato N
Intractable Rare Dis Res. 2024; 13(1):1-11.
DOI: 10.5582/irdr.2023.01113
-
12-22
The use of artificial intelligence in the treatment of rare diseases: A scoping review
He D, Wang R, Xu ZL, Wang JN, Song PP, Wang HY, Su JY
Intractable Rare Dis Res. 2024; 13(1):12-22.
DOI: 10.5582/irdr.2023.01111
-
23-28
Situs viscerum inversus and abdominal aortic aneurysm: A systematic review of a rare association
Ossola P, Mascioli F, Luzzi AP, Epis L, Coletta D
Intractable Rare Dis Res. 2024; 13(1):23-28.
DOI: 10.5582/irdr.2023.01081
-
29-35
Lan FY, Chen ZZ, Lin XL
Intractable Rare Dis Res. 2024; 13(1):29-35.
DOI: 10.5582/irdr.2023.01100
-
36-41
Machida O, Sakamoto H, Shimojima Yamamoto K, Hasegawa Y, Nii S, Okada H, Nishikawa K, Sumimoto S, Nishi E, Okamoto N, Yamamoto T
Intractable Rare Dis Res. 2024; 13(1):36-41.
DOI: 10.5582/irdr.2023.01119
-
42-50
Role of IFITM2 in osteogenic differentiation of C3H10T1/2 mesenchymal stem cells
Zhang Y, Li X, Zhang S, Li J, Liu M, Lu Y, Han J
Intractable Rare Dis Res. 2024; 13(1):42-50.
DOI: 10.5582/irdr.2023.01108
-
51-56
Qiu H, Wang Z, Liu BN, Sun RZ, Tian XY, Hao CY
Intractable Rare Dis Res. 2024; 13(1):51-56.
DOI: 10.5582/irdr.2023.01112
-
57-62
Emotional journey of patients with specified intractable diseases in Japan
Tanaka H, Shimaoka M
Intractable Rare Dis Res. 2024; 13(1):57-62.
DOI: 10.5582/irdr.2023.01115
-
63-68
Shimizu T, Yoshida H, Taniai N, Yoshioka M, Kawano Y, Matsushita A, Ueda J, Iwai T, Murokawa T, Ono T, Hamaguchi A
Intractable Rare Dis Res. 2024; 13(1):63-68.
DOI: 10.5582/irdr.2023.01106
-
69-72
Wiskott-Aldrich syndrome: A new synonym mutation in the WAS gene
Sun YX, Song XM, Pan H, Li XX, Sun LR, Song L, Ma F, Hao JN
Intractable Rare Dis Res. 2024; 13(1):69-72.
DOI: 10.5582/irdr.2023.01102